The Distribution of the Genotypes of ABCB1 and CES1 Polymorphisms in Kazakhstani Patients with Atrial Fibrillation Treated with DOAC
Genes · 29.05.2023 · 14 (6) · 1192
DOI: 10.3390/genes14061192 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, online erschienen am 29.05.2023. Verfasst von Ayan Abdrakhmanov und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Research Cardiac Surgery Center, Astana 010000, Kazakhstan. Hauptthemen laut MEDLINE: Dabigatran, Atrial Fibrillation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Republic of Kazakhstan.
Abstract (Originalsprache)
Nowadays, direct oral anticoagulants (DOACs) are the first-line anticoagulant strategy in patients with non-valvular atrial fibrillation (NVAF). We aimed to identify the influence of polymorphisms of the genes encoding P-glycoprotein (ABCB1) and carboxylesterase 1 (CES1) on the variability of plasma concentrations of DOACs in Kazakhstani patients with NVAF. We analyzed polymorphisms rs4148738, rs1045642, rs2032582 and rs1128503 in ABCB1 and rs8192935, rs2244613 and rs71647871 CES1 genes and measured the plasma concentrations of dabigatran/apixaban and biochemical parameters in 150 Kazakhstani NVAF patients. Polymorphism rs8192935 in the CES1 gene (p = 0.04), BMI (p = 0.01) and APTT level (p = 0.01) were statistically significant independent factors of trough plasma concentration of dabigatran. In contrast, polymorphisms rs4148738, rs1045642, rs2032582 and rs1128503 in ABCB1 and rs8192935, rs2244613 and rs71647871 CES1 genes did not show significant influence on plasma concentrations of dabigatran/apixaban drugs (p > 0.05). Patients with GG genotype (138.8 ± 100.1 ng/mL) had higher peak plasma concentration of dabigatran than with AA genotype (100.9 ± 59.6 ng/mL) and AG genotype (98.7 ± 72.3 ng/mL) (Kruskal–Wallis test, p = 0.25). Thus, CES1 rs8192935 is significantly associated with plasma concentrations of dabigatran in Kazakhstani NVAF patients (p < 0.05). The level of the plasma concentration shows that biotransformation of the dabigatran processed faster in individual carriers of GG genotype rs8192935 in the CES1 gene than with AA genotype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Research Cardiac Surgery Center, Astana 010000, Kazakhstan.
- Medical Centre Hospital of President's Affairs Administration of the Republic of Kazakhstan, Astana 010000, Kazakhstan.
- Center for Life Sciences, National Laboratory Astana, Nazarbayev University, Astana 010000, Kazakhstan.
- Department of Internal Medicine, Medical University Astana, Astana 010000, Kazakhstan.
- Corporate Fund "University Medical Center", Nazarbayev University, Astana 010000, Kazakhstan.
ORCID-Profile: Ainur Akilzhanova
Förderung
- Ministry of Science and Higher Education of the Republic of Kazakhstan
Zitieren
APA
Abdrakhmanov, A., Akilzhanova, A., Shaimerdinova, A., Zhalbinova, M., Tuyakova, G., Abildinova, S., Albayev, R., Ainabekova, B., Chinybayeva, A., Suleimen, Z., & Bekbossynova, M. (2023). The Distribution of the Genotypes of ABCB1 and CES1 Polymorphisms in Kazakhstani Patients with Atrial Fibrillation Treated with DOAC. Genes, 14(6), 1192. https://doi.org/10.3390/genes14061192
Vancouver
Abdrakhmanov A, Akilzhanova A, Shaimerdinova A, Zhalbinova M, Tuyakova G, Abildinova S, et al. The Distribution of the Genotypes of ABCB1 and CES1 Polymorphisms in Kazakhstani Patients with Atrial Fibrillation Treated with DOAC. Genes. 2023;14(6):1192. doi:10.3390/genes14061192
BibTeX
@article{Abdrakhmanov2023,
author = {Abdrakhmanov, Ayan and Akilzhanova, Ainur and Shaimerdinova, Aizhan and Zhalbinova, Madina and Tuyakova, Gulnara and Abildinova, Svetlana and Albayev, Rustam and Ainabekova, Bayan and Chinybayeva, Assel and Suleimen, Zhanasyl and Bekbossynova, Makhabbat},
title = {The Distribution of the Genotypes of ABCB1 and CES1 Polymorphisms in Kazakhstani Patients with Atrial Fibrillation Treated with DOAC},
journal = {Genes},
year = {2023},
volume = {14},
number = {6},
pages = {1192},
doi = {10.3390/genes14061192}
}
EUVIMED